0001209191-22-040781.txt : 20220705
0001209191-22-040781.hdr.sgml : 20220705
20220705170053
ACCESSION NUMBER: 0001209191-22-040781
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220630
FILED AS OF DATE: 20220705
DATE AS OF CHANGE: 20220705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sharei Armon
CENTRAL INDEX KEY: 0001829463
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39662
FILM NUMBER: 221066098
MAIL ADDRESS:
STREET 1: C/O SQZ BIOTECHNOLOGIES COMPANY
STREET 2: 200 ARSENAL YARDS BOULEVARD, SUITE 210
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SQZ Biotechnologies Co
CENTRAL INDEX KEY: 0001604477
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462431115
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., STE. 210
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-898-8824
MAIL ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., STE. 210
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-30
0
0001604477
SQZ Biotechnologies Co
SQZ
0001829463
Sharei Armon
200 ARSENAL YARDS BLVD, SUITE 210
WATERTOWN
MA
02472
1
1
0
0
President and CEO
Common Stock
2022-06-30
5
A
0
E
2436
2.703
A
287884
D
The reporting person is voluntarily reporting the acquisition on June 30, 2022 of 2,436 shares of the issuer's common stock pursuant to the issuer's employee stock purchase plan.
/s/ Lawrence Knopf, Attorney-in-Fact for Armon Sharei
2022-07-05